<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://pharmacopedia.wiki/index.php?action=history&amp;feed=atom&amp;title=Clindamycin</id>
	<title>Clindamycin - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://pharmacopedia.wiki/index.php?action=history&amp;feed=atom&amp;title=Clindamycin"/>
	<link rel="alternate" type="text/html" href="https://pharmacopedia.wiki/index.php?title=Clindamycin&amp;action=history"/>
	<updated>2026-05-28T18:48:42Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.46.0-beta</generator>
	<entry>
		<id>https://pharmacopedia.wiki/index.php?title=Clindamycin&amp;diff=6908&amp;oldid=prev</id>
		<title>MDElliottMD: home-claude category backfill (parser-claude gap closure)</title>
		<link rel="alternate" type="text/html" href="https://pharmacopedia.wiki/index.php?title=Clindamycin&amp;diff=6908&amp;oldid=prev"/>
		<updated>2026-05-23T10:43:45Z</updated>

		<summary type="html">&lt;p&gt;home-claude category backfill (parser-claude gap closure)&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw-interface=&quot;&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;en&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Older revision&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Revision as of 10:43, 23 May 2026&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l21&quot;&gt;Line 21:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 21:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;== References ==&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;== References ==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;lt;references /&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;lt;references /&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;[[Category:Lincosamides]]&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;[[Category:Antibacterials]]&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>MDElliottMD</name></author>
	</entry>
	<entry>
		<id>https://pharmacopedia.wiki/index.php?title=Clindamycin&amp;diff=6492&amp;oldid=prev</id>
		<title>MDElliottMD: parser-claude batch MedTemplate pre-fill, Top 300 #149</title>
		<link rel="alternate" type="text/html" href="https://pharmacopedia.wiki/index.php?title=Clindamycin&amp;diff=6492&amp;oldid=prev"/>
		<updated>2026-05-23T04:21:34Z</updated>

		<summary type="html">&lt;p&gt;parser-claude batch MedTemplate pre-fill, Top 300 #149&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;{{MedTemplate&lt;br /&gt;
| generic           = Clindamycin&lt;br /&gt;
| brand             = Cleocin (oral, IV); Clindesse, Cleocin (vaginal); Clindets, Cleocin T (topical)&lt;br /&gt;
| structure         =&lt;br /&gt;
| classes           = [[:Category:Lincosamides|Lincosamide antibiotic]], [[:Category:Antibacterials|Antibacterial]]&lt;br /&gt;
| uses              = &amp;lt;vote slug=&amp;quot;ssti-use&amp;quot;&amp;gt;Skin and soft tissue infections (including some MRSA strains)&amp;lt;/vote&amp;gt;, &amp;lt;vote slug=&amp;quot;dental-anaerobic-use&amp;quot;&amp;gt;Anaerobic odontogenic infections&amp;lt;/vote&amp;gt;, &amp;lt;vote slug=&amp;quot;bacterial-vaginosis-use&amp;quot;&amp;gt;Bacterial vaginosis (vaginal)&amp;lt;/vote&amp;gt;, &amp;lt;vote slug=&amp;quot;acne-vulgaris-topical-use&amp;quot;&amp;gt;Acne vulgaris (topical, often with benzoyl peroxide)&amp;lt;/vote&amp;gt;, &amp;lt;vote slug=&amp;quot;strep-toxic-shock-use&amp;quot;&amp;gt;Adjunct to β-lactam in toxin-mediated streptococcal/staphylococcal infections (toxic shock, necrotizing fasciitis) for ribosomal suppression of toxin production&amp;lt;/vote&amp;gt;, &amp;lt;vote slug=&amp;quot;dental-prophylaxis-pcn-allergic-use&amp;quot;&amp;gt;Dental prophylaxis in penicillin allergy&amp;lt;/vote&amp;gt;&lt;br /&gt;
| starting_dose     = Oral 300-450 mg PO QID; IV 600-900 mg q8h; topical 1% solution/gel BID; vaginal 100 mg ovule × 3 days or 2% cream × 7 days&lt;br /&gt;
| preparations      = 75, 150, 300 mg capsules; 75 mg/5 mL solution; 150 mg/mL IV; 1% topical; 2% vaginal cream&lt;br /&gt;
| fda_max           = 4.8 g/d (IV severe infection)&lt;br /&gt;
| pill_id           =&lt;br /&gt;
| routes            = Oral, IV, IM, topical, vaginal&lt;br /&gt;
| onset             = Hours&lt;br /&gt;
| duration          = 6-8 hours&lt;br /&gt;
| halflife          = ~2.5-3 hours&amp;lt;ref name=&amp;quot;cleocin-label&amp;quot;&amp;gt;FDA Prescribing Information, Cleocin HCl (clindamycin HCl), Pfizer, current revision. https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/050162s100lbl.pdf&amp;lt;/ref&amp;gt;&lt;br /&gt;
| bioavailability   = ~90% (oral)&amp;lt;ref name=&amp;quot;cleocin-label&amp;quot; /&amp;gt;&lt;br /&gt;
| pregnancy         = Generally considered safe.{{citation needed}}&lt;br /&gt;
| legal             = [[USLegal:Prescription only|Rx-only]] in US. Carries a &amp;#039;&amp;#039;&amp;#039;Boxed Warning&amp;#039;&amp;#039;&amp;#039; for Clostridioides difficile colitis (one of the most C. difficile-inducing antibiotic classes)&amp;lt;ref name=&amp;quot;cleocin-label&amp;quot; /&amp;gt;&lt;br /&gt;
| mechanism         = &amp;lt;vote slug=&amp;quot;clindamycin-mech-claim&amp;quot;&amp;gt;Clindamycin reversibly binds the 23S rRNA of the bacterial 50S ribosomal subunit at a site overlapping the macrolide binding site, blocking peptide bond formation and inhibiting protein synthesis; the result is bacteriostatic against most organisms and bactericidal at high concentrations against susceptible strains.&amp;lt;/vote&amp;gt; Active against gram-positives (Staph including some MRSA, streptococci including viridans), anaerobes (Bacteroides, Clostridia other than difficile, Peptostreptococcus), and Toxoplasma. Inducible MLSb resistance (D-test required for staph) and rising community MRSA resistance limit empiric reliability. Strong association with C. difficile colitis is the clinical-use ceiling&amp;lt;ref name=&amp;quot;cleocin-label&amp;quot; /&amp;gt;.&lt;br /&gt;
}}&lt;br /&gt;
&lt;br /&gt;
== References ==&lt;br /&gt;
&amp;lt;references /&amp;gt;&lt;/div&gt;</summary>
		<author><name>MDElliottMD</name></author>
	</entry>
</feed>